Company intelligence / Profile preview

FarmaSyn

Pefko Spiridonos Rikia, Greece

Ownership: Private
Employees: ~61
Development stage: Other

Overview

FarmaSyn is a Greek pharmaceutical company with nearly 30 years of experience in manufacturing and distributing a broad portfolio of both established and innovative medicinal products, spanning multiple therapeutic categories. The company emphasizes quality, reliability, and patient access, working in collaboration with large pharmaceutical companies in Greece and abroad, as well as developing its own products. FarmaSyn’s manufacturing facility is described as state-of-the-art, adhering to rigorous industry standards for hygiene and sterility[1][3][4].

Modalities: Small moleculeBiologic
Industry: Biotech

Drug pipeline

7 assets

Nasasyn

Unknown

6 more assets in the full pipeline.

Request access →

Partnerships

Cooperation with large pharmaceutical companies in Greece and abroad[1]

Beyond the preview

Go deeper on FarmaSyn.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FarmaSyn.

Explore the full profile